AAMC is retired as a standalone methodology. Founder decision 2026-05-22: with the pivot to "the Inference for AI Agents", there is no trust-marketplace to adjudicate. AAMC existed to make a neutral agent-trust exchange credible; the new thesis sells routing inference, not adjudicated agent trust. To stay focused, only Routing + Ontology remain live methodologies.
Where the value goes:
- Routing-governance (was a routing change picked fairly? was a provider down-weighted honestly?) → folds into Routing as a governance concern, not a 5-model council.
- Provider quality / health → already in Routing (
h(m,t)health term + provider-regression watch).
- Multi-model consensus as a future product (adjudication-as-a-service) → may be revived post-Series A if there's demand; not pre-Seed canon.
This page is preserved as historical record (the 5-voter design, tiered T1/T2/T3 structure, and self-preference prohibition may inform future governance if revived). It is not canon and not a build target. AIN-242 closed as superseded.
Retired by founder 2026-05-22 to reduce methodology surface and focus on the product (Routing) + substrate (Ontology).
canonical: true
version: 1.0
locked: 2026-05-10
parent: ainfera_hq
spec_lineage: refactored from May 8 pressure-test doc for new exchange thesis
model_count: 5 (odd-numbered for clean supermajority)
lens_count: 5